BioIntelliSense, a continuous health monitoring and clinical intelligence company with medical-grade wearable devices and Data-as-a-Service.
BioIntelliSense has raised $58.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
BioIntelliSense's investors include 7wire Ventures, U.S. Department of War, Chimera Investment, Fresenius Medical Care, Fresenius Medical Care North America.
BioIntelliSense is headquartered in Golden, United States.
BioIntelliSense, a continuous health monitoring and clinical intelligence company with medical-grade wearable devices and Data-as-a-Service.
BioIntelliSense is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioIntelliSense — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/biointellisense. Accessed September 30, 2026.
VCBacked. (2025). BioIntelliSense — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biointellisense
{{cite web |title=BioIntelliSense — Funding & Investors |url=https://www.vcbacked.co/company/biointellisense |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated